These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7671060)

  • 1. [Role of urapidil in the treatment of acute hypertension].
    Lehot JJ; Bonnefoy E; Dalmas JP; Filley S; Bastien O; George M
    Cah Anesthesiol; 1995; 43(1):67-76. PubMed ID: 7671060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic haemodynamic and humoral changes during urapidil treatment in hypertensive patients.
    Leonetti G; Terzoli L; Zanchetti A
    J Hypertens Suppl; 1988 Dec; 6(2):S25-9. PubMed ID: 2906697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of phentolamine and urapidil in controlling acute intra-operative hypertension in patients subjected to coronary artery bypass surgery.
    Hess W; Schulte-Sasse U; Tarnow J; Veit S
    Eur J Anaesthesiol; 1985 Mar; 2(1):21-7. PubMed ID: 3874774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of the hypertensive crisis with urapidil. Various effects on patients with or without coronary disease].
    Zähringer J; Klepzig M; Greif J; Ludwig B; Strauer B
    Fortschr Med; 1984 Jun; 102(22):624-8. PubMed ID: 6469170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
    Adnot S; Samoyeau R; Weitzenblum E
    Blood Press Suppl; 1995; 3():47-57. PubMed ID: 8535542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of urapidil by intravenous injection on pulmonary circulation and cardiac function in left ventricular failure].
    Drobinski G; Montalescot G; Fossier JM; Grosgogeat Y
    Ann Cardiol Angeiol (Paris); 1993 Mar; 42(3):167-72. PubMed ID: 8498805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology of urapidil.
    Prichard BN; Renondin JC; Tomlinson B
    J Hypertens Suppl; 1988 Dec; 6(2):S13-9. PubMed ID: 2906695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of urapidil and nitroprusside on hemodynamics and myocardial function in hypertension following cardiac surgery.
    Van der Stroom JG; Van Wezel HB; Koolen JJ; Visser CA; Van Zwieten PA
    Blood Press Suppl; 1994; 4():31-8. PubMed ID: 7804510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urapidil, a dual-acting antihypertensive agent: Current usage considerations.
    Buch J
    Adv Ther; 2010 Jul; 27(7):426-43. PubMed ID: 20652659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of haemodynamic effects of nitric oxide on post-capillary pulmonary hypertension induced by acute sino-aortic denervation.
    Galinier M; Rougé P; Fourcade J; Senard JM; Albenque JP; Balanescu S; Doazan JP; Montastruc JL; Bounhoure JP; Montastruc P
    Br J Pharmacol; 1997 Jan; 120(1):7-12. PubMed ID: 9117101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic changes and left ventricular function in patients with hypertension during an acute trial of urapidil].
    Sirakova V; Penkov N; Penev A
    Vutr Boles; 1988; 27(5):20-3. PubMed ID: 3062899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacologic profile of urapidil. Consequences for use as an antihypertensive drug].
    van Zwieten PA
    Fortschr Med; 1992 Jun; 110(17):330-2. PubMed ID: 1353745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective antihypertensive therapy: blood pressure control with moxonidine.
    Prichard BN; Graham BR
    J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S38-48. PubMed ID: 8872298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension and cardiac decompensation].
    Degaute JP
    Rev Med Brux; 1996 Sep; 17(4):272-4. PubMed ID: 8927860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global and regional haemodynamic effects of urapidil in conscious dogs with chronic coronary artery occlusion.
    Wouters PF; Marcus MA; Van Aken HK; van de Velde M; Miserez M; Deruyter HA; Mignolet K; Flameng W
    Eur J Anaesthesiol; 1994 Sep; 11(5):381-90. PubMed ID: 7988582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Today's strategies for treating postoperative hypertension. Immediate evaluation and targeted treatment are required.
    Halpern NA
    J Crit Illn; 1995 Jul; 10(7):478-80, 483-90. PubMed ID: 10150580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of hypertension during cardiopulmonary bypass with urapidil and phentolamine.
    Göb E; Barankay A; Richter JA
    Arzneimittelforschung; 1981; 31(9):1479-81. PubMed ID: 7197959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.